JPH01228484A - Antibiotic substance wk-1875 and production thereof - Google Patents
Antibiotic substance wk-1875 and production thereofInfo
- Publication number
- JPH01228484A JPH01228484A JP63055558A JP5555888A JPH01228484A JP H01228484 A JPH01228484 A JP H01228484A JP 63055558 A JP63055558 A JP 63055558A JP 5555888 A JP5555888 A JP 5555888A JP H01228484 A JPH01228484 A JP H01228484A
- Authority
- JP
- Japan
- Prior art keywords
- culture
- antibiotic
- methanol
- antibiotic substance
- magnetic resonance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000126 substance Substances 0.000 title claims abstract description 16
- 230000003115 biocidal effect Effects 0.000 title claims abstract description 13
- 238000004519 manufacturing process Methods 0.000 title claims description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims abstract description 42
- BNVZCZJOQPRHLO-SMUQHDSOSA-N (1S,3S,5'S,6S,6'S,8S,9E,14R,15R,17S,18R,19S,20R,21E,25S,27R,29R)-3,14,15,17,19,20-hexahydroxy-6'-[(2R)-2-hydroxybutyl]-5',6,14,18,20,29-hexamethylspiro[4,24,28-trioxatricyclo[23.3.1.03,8]nonacosa-9,21-diene-27,2'-oxane]-23-one Chemical compound CC[C@@H](O)C[C@@H]1O[C@@]2(CC[C@@H]1C)C[C@@H]1OC(=O)\C=C\[C@@](C)(O)[C@@H](O)[C@H](C)[C@@H](O)C[C@@H](O)[C@](C)(O)CCC\C=C\[C@@H]3C[C@H](C)CO[C@@]3(O)C[C@H](O2)[C@H]1C BNVZCZJOQPRHLO-SMUQHDSOSA-N 0.000 claims abstract description 25
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims abstract description 20
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims abstract description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000003242 anti bacterial agent Substances 0.000 claims abstract description 7
- 241000187747 Streptomyces Species 0.000 claims abstract description 5
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims abstract description 5
- 238000010521 absorption reaction Methods 0.000 claims abstract description 4
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 claims abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 4
- 238000000921 elemental analysis Methods 0.000 claims abstract description 3
- 238000002844 melting Methods 0.000 claims abstract description 3
- 230000008018 melting Effects 0.000 claims abstract description 3
- 238000000034 method Methods 0.000 claims description 12
- 238000006243 chemical reaction Methods 0.000 claims description 6
- 238000000862 absorption spectrum Methods 0.000 claims description 5
- 230000002378 acidificating effect Effects 0.000 claims description 4
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 230000007935 neutral effect Effects 0.000 claims description 2
- 230000003287 optical effect Effects 0.000 claims description 2
- 239000000463 material Substances 0.000 claims 1
- 239000000047 product Substances 0.000 abstract description 5
- 238000005273 aeration Methods 0.000 abstract description 4
- 238000012258 culturing Methods 0.000 abstract description 3
- 239000000706 filtrate Substances 0.000 abstract description 3
- 230000000813 microbial effect Effects 0.000 abstract description 3
- 241000233866 Fungi Species 0.000 abstract description 2
- 239000003905 agrochemical Substances 0.000 abstract description 2
- 239000002952 polymeric resin Substances 0.000 abstract description 2
- 229920003002 synthetic resin Polymers 0.000 abstract description 2
- 238000013019 agitation Methods 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 230000003032 phytopathogenic effect Effects 0.000 abstract 1
- 238000000926 separation method Methods 0.000 abstract 1
- 239000002609 medium Substances 0.000 description 16
- 229920001817 Agar Polymers 0.000 description 9
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 9
- 239000008272 agar Substances 0.000 description 9
- 239000000741 silica gel Substances 0.000 description 9
- 229910002027 silica gel Inorganic materials 0.000 description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 6
- 229940088710 antibiotic agent Drugs 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 239000001888 Peptone Substances 0.000 description 4
- 108010080698 Peptones Proteins 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 235000019319 peptone Nutrition 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 230000000843 anti-fungal effect Effects 0.000 description 3
- 229940121375 antifungal agent Drugs 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 3
- 210000002421 cell wall Anatomy 0.000 description 3
- 235000019441 ethanol Nutrition 0.000 description 3
- -1 for example Substances 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- GMKMEZVLHJARHF-UHFFFAOYSA-N (2R,6R)-form-2.6-Diaminoheptanedioic acid Natural products OC(=O)C(N)CCCC(N)C(O)=O GMKMEZVLHJARHF-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 241000235526 Mucor racemosus Species 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- GMKMEZVLHJARHF-SYDPRGILSA-N meso-2,6-diaminopimelic acid Chemical compound [O-]C(=O)[C@@H]([NH3+])CCC[C@@H]([NH3+])C([O-])=O GMKMEZVLHJARHF-SYDPRGILSA-N 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 238000011218 seed culture Methods 0.000 description 2
- 235000020183 skimmed milk Nutrition 0.000 description 2
- 235000002639 sodium chloride Nutrition 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 241000186361 Actinobacteria <class> Species 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 239000004254 Ammonium phosphate Substances 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 235000021513 Cinchona Nutrition 0.000 description 1
- 241000157855 Cinchona Species 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- IIUZTXTZRGLYTI-UHFFFAOYSA-N Dihydrogriseofulvin Natural products COC1CC(=O)CC(C)C11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 IIUZTXTZRGLYTI-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 238000006424 Flood reaction Methods 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- UXWOXTQWVMFRSE-UHFFFAOYSA-N Griseoviridin Natural products O=C1OC(C)CC=C(C(NCC=CC=CC(O)CC(O)C2)=O)SCC1NC(=O)C1=COC2=N1 UXWOXTQWVMFRSE-UHFFFAOYSA-N 0.000 description 1
- 101100019528 Homo sapiens KRT71 gene Proteins 0.000 description 1
- 102100025370 Keratin, type II cytoskeletal 71 Human genes 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000235395 Mucor Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000187480 Mycobacterium smegmatis Species 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- DDUHZTYCFQRHIY-UHFFFAOYSA-N Negwer: 6874 Natural products COC1=CC(=O)CC(C)C11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 DDUHZTYCFQRHIY-UHFFFAOYSA-N 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000233629 Phytophthora parasitica Species 0.000 description 1
- 229930182764 Polyoxin Natural products 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000187180 Streptomyces sp. Species 0.000 description 1
- NKNPHSJWQZXWIX-UHFFFAOYSA-N Tetranactin Natural products CC1C(=O)OC(CC)CC(O2)CCC2C(C)C(=O)OC(CC)CC(O2)CCC2C(C)C(=O)OC(CC)CC(O2)CCC2C(C)C(=O)OC(CC)CC2CCC1O2 NKNPHSJWQZXWIX-UHFFFAOYSA-N 0.000 description 1
- NKNPHSJWQZXWIX-DCVDGXQQSA-N Tetranactin Chemical compound C[C@H]([C@H]1CC[C@H](O1)C[C@@H](OC(=O)[C@@H](C)[C@@H]1CC[C@@H](O1)C[C@@H](CC)OC(=O)[C@H](C)[C@H]1CC[C@H](O1)C[C@H](CC)OC(=O)[C@H]1C)CC)C(=O)O[C@H](CC)C[C@H]2CC[C@@H]1O2 NKNPHSJWQZXWIX-DCVDGXQQSA-N 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- 229930195482 Validamycin Natural products 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 238000002814 agar dilution Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- PNNNRSAQSRJVSB-BXKVDMCESA-N aldehydo-L-rhamnose Chemical compound C[C@H](O)[C@H](O)[C@@H](O)[C@@H](O)C=O PNNNRSAQSRJVSB-BXKVDMCESA-N 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 229910000148 ammonium phosphate Inorganic materials 0.000 description 1
- 235000019289 ammonium phosphates Nutrition 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 244000000005 bacterial plant pathogen Species 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- DLRVVLDZNNYCBX-ZZFZYMBESA-N beta-melibiose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)O1 DLRVVLDZNNYCBX-ZZFZYMBESA-N 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000001058 brown pigment Substances 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 239000013058 crude material Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000012156 elution solvent Substances 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 244000000004 fungal plant pathogen Species 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229960002867 griseofulvin Drugs 0.000 description 1
- DDUHZTYCFQRHIY-RBHXEPJQSA-N griseofulvin Chemical compound COC1=CC(=O)C[C@@H](C)[C@@]11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 DDUHZTYCFQRHIY-RBHXEPJQSA-N 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 235000006180 nutrition needs Nutrition 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- YEBIHIICWDDQOL-YBHNRIQQSA-N polyoxin Polymers O[C@@H]1[C@H](O)[C@@H](C(C=O)N)O[C@H]1N1C(=O)NC(=O)C(C(O)=O)=C1 YEBIHIICWDDQOL-YBHNRIQQSA-N 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- NBDQGOCGYHMDSJ-NRFPMOEYSA-M sodium;(e,3r,5s)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoate Chemical compound [Na+].[O-]C(=O)C[C@H](O)C[C@H](O)\C=C\C1=C(C2CC2)N=C2C=CC=CC2=C1C1=CC=C(F)C=C1 NBDQGOCGYHMDSJ-NRFPMOEYSA-M 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- JARYYMUOCXVXNK-IMTORBKUSA-N validamycin Chemical compound N([C@H]1C[C@@H]([C@H]([C@H](O)[C@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)CO)[C@H]1C=C(CO)[C@H](O)[C@H](O)[C@H]1O JARYYMUOCXVXNK-IMTORBKUSA-N 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
Abstract
Description
【発明の詳細な説明】
先l上夏遭皿分1
本発明は抗生物質に関し、特に新規抗生物質WK−18
75およびその製法に関する。[Detailed description of the invention] The present invention relates to antibiotics, and particularly to the novel antibiotic WK-18.
75 and its manufacturing method.
I股五且浦
抗真菌性抗生物質として、例えば、アムホテリン、グリ
セオフルビン、ビロールニドリン等の医薬や、プラスナ
シジンS1ポリオキシン、バリダマイシン、テトラナク
チン等の農薬が知られている。しかし公知の抗真菌性抗
生物質は、例えば、薬効、毒性、抗菌性等の点において
なお改良の余地がある0本発明は、発明者が土壌から分
離した放線菌が、特に植物病原菌に対して強い活性をも
つ抗真菌性抗生物質を生産 する能力を有するという知
見に基すいている。As antifungal antibiotics, for example, pharmaceuticals such as amphoterine, griseofulvin, and virolnidrine, and agricultural chemicals such as plusnacidin S1 polyoxin, validamycin, and tetranactin are known. However, there is still room for improvement in the known antifungal antibiotics, for example, in terms of efficacy, toxicity, antibacterial properties, etc. The present invention shows that actinomycetes isolated from soil by the inventors are particularly effective against plant pathogenic bacteria. It is based on the knowledge that it has the ability to produce antifungal antibiotics with strong activity.
、 が じようとする二皿
本発明の目的は、新規抗生物質WK−1875およびそ
の製法を提供することにある。An object of the present invention is to provide a novel antibiotic WK-1875 and a method for producing the same.
・題を するための
本発明により、抗生物質WK−1875が提供される0
本抗生物質の理化学的性質は次の通りである。・According to the present invention, antibiotic WK-1875 is provided.
The physicochemical properties of this antibiotic are as follows.
■ 融点:116−119℃
■ 元素分析二実測(直(%)
C64,7±l、O
H9,l±0.3
■ 分子51ニア40.97
■ 分子式二04゜H6゜O+X
■ 比旋光度:[α] −12,1’(c=0.5
.メタノール)
■ 紫外線吸収スペクトル(メタノール中)二木端吸収
■ 赤外線吸収スペクトル(KBr法):第1図の通り
■ プロトン核磁気共鳴スペクトル(CDC1,中):
第2図の通り
■ C−13核磁気共鳴スペクトル+CDCl、中):
第3図の通り
[相] 溶剤に対する溶解性
可78=メタノール、エタノール、酢酸エチル、クロロ
ホルム
不溶:水、n−ヘキサン
■ 呈色反応
陽性: H,SO。■ Melting point: 116-119℃ ■ Elemental analysis 2 actual measurements (direct (%) C64,7±l, O H9,1±0.3 ■ Molecule 51 near 40.97 ■ Molecular formula 204゜H6゜O+X ■ Specific optical rotation : [α] -12,1' (c=0.5
.. (Methanol) ■ Ultraviolet absorption spectrum (in methanol) Nikita absorption ■ Infrared absorption spectrum (KBr method): As shown in Figure 1 ■ Proton nuclear magnetic resonance spectrum (CDC1, in middle):
As shown in Figure 2 ■ C-13 nuclear magnetic resonance spectrum + CDCl, medium):
As shown in Figure 3 [Phase] Soluble in solvents Possible 78 = methanol, ethanol, ethyl acetate, chloroform Insoluble: water, n-hexane ■ Positive color reaction: H, SO.
陰性・エールリッヒ反応、ドラーゲンドルフ反応
@ 酸性、中性、塩基性の別:弱酸性物質@ 物質の色
:白色
本抗生物質の生物学的性質は次の通りである。Negative/Ehrlich reaction, Dragendorff reaction @ Classification of acidic, neutral, and basic: Weakly acidic substance @ Color of substance: White The biological properties of antibiotics are as follows.
l)抗菌活性
第1表は、寒天希釈法による本抗生物質の最小発育阻止
濃度(MIC,用位μg/m氾)を示す。l) Antibacterial activity Table 1 shows the minimum inhibitory concentration (MIC, microg/m concentration) of this antibiotic by the agar dilution method.
第 1 表
−MIC
ニジエリチア・コリ(Escherichia col
i) > l口OKB+76 (NIHJ、JC−2,
IFO12734) *シュードモナス・エルギノーザ
> 100(Ploo(Pseudo 規匹■
匹胚) P−3に旧05 Iキサントモナス・オリザエ
〉l00(Xar+Lhomonas 吐
■鱈l KB88 *零ミクロコツカス・ルテウス
〉100(Microcoloo(1uteu
sl にB2O(PcI+00116スタフイロコツカ
ス・アウレウス 〉100(Sta h 1oco
ccus aureus) KB34(FDA 209
P)書
ミコバクテリウム・スメグマチス 〉100(リョ
江旦11憇肛那1唄堕) KB42(ATCC6071
I
バチルス・スブチリス 〉l00(Ba
cillus 5ubtilis) KB27 (PC
I 2191 *カンジダ・アルビカンス
〉100(Candida aLbicansl
KFI 参傘サツカロミセス・サケ
〉1100(Saccharo ces 5ake)
にF26 **アスペルギルス・ニガー
〉100(へ旦Ps」]LLVL見旦 l[区旦工I
KFI口3(ATCC62751*番
ビリキュラリア・オリザエ 5.25(
Piricularia ρニy旦旦り にF18
0 参ネムコール・ラセモスス 3
12(Mucor rasemosusl KF223
(IFo 45811 傘$
フィトフィトーラ・バラシチカ 1.56注
: * 感受性寒天培地 (日本製)37℃、pH7,
0,24時間目に判定。Table 1 - MIC Escherichia coli
i) > 1 OKB+76 (NIHJ, JC-2,
IFO12734) *Pseudomonas aeruginosa > 100 (Ploo (Pseudo)
Xar + Lhomonas KB88
〉100(Microcoloo(1uteu)
sl to B2O (PcI + 00116 Staphylococcus aureus > 100 (Sta h 1oco
ccus aureus) KB34 (FDA 209
P) Mycobacterium smegmatis 〉100 (Ryo Edan 11 Ean 1 song fall) KB42 (ATCC6071
I Bacillus subtilis 〉l00(Ba
cillus 5ubtilis) KB27 (PC
I 2191 *Candida albicans
〉100(Candida aLbicansl
KFI Satsukalomyces salmon
〉1100(Saccharoces 5ake)
to F26 ** Aspergillus niger
〉100(HedanPs”) LLVLMidan l[Kudanko I
KFI port 3 (ATCC62751* No. Biricularia oryzae 5.25 (
Piricularia ρniytandanri ni F18
0 Nemcor racemosus 3
12 (Mucor racemosusl KF223
(IFo 45811 Umbrella $ Phytophytola balasitica 1.56 Note: * Sensitive agar medium (made in Japan) 37℃, pH 7,
Judgment was made at 0 and 24 hours.
$参 ポテトグルコース寒天培地 27℃、H6,Ol
3日 に 。$3 Potato glucose agar medium 27℃, H6, Ol
On the 3rd.
本抗生物質は、前記の通り、例えばビラキュラリア(P
iricularial属の真菌に対して強い活性を示
す。As mentioned above, the present antibiotic is, for example, Viracularia (P
Shows strong activity against fungi of the genus Iricularial.
2)毒性
マウスに投与した場合の本抗生物質の急性毒性(L D
!。)は、30 ff1g/kg (腹腔内)以上
または100mg/kg (経口)以上であった。2) Acute toxicity of this antibiotic when administered to toxic mice (L D
! . ) was 30 ff1g/kg (intraperitoneal) or more or 100 mg/kg (oral) or more.
次に本発明により、ストレプトミセス属に属しかつ抗生
物質WK−1875産生能力を有する微生物を培地に好
気的に培養し、培養物中に抗生物質WK−1875を蓄
積し、培養物からこれを採取する工程からなる、抗生物
質WK−1875の製法が提供される。Next, according to the present invention, a microorganism belonging to the genus Streptomyces and having the ability to produce the antibiotic WK-1875 is aerobically cultured in a medium, the antibiotic WK-1875 is accumulated in the culture, and the antibiotic WK-1875 is removed from the culture. A method for producing antibiotic WK-1875 is provided, comprising the step of harvesting.
本発明の抗生物質WK−1875を生産するために使用
される菌株としては、1例として、本発明者らによって
東京湾岸の土壌から新たに分離された、ストレプトミセ
ス・エスピー・WK−1875株が挙げられる。As an example of the strain used to produce the antibiotic WK-1875 of the present invention, Streptomyces sp. WK-1875 strain, which was newly isolated by the present inventors from the soil of Tokyo Bay, is Can be mentioned.
本菌株の菌学的性状は次のとおりである。The mycological properties of this strain are as follows.
[1形態的性質
栄養菌糸は各種寒天培地上でよく発達し、分断は観察さ
れない、気菌糸は酵母エキス・麦芽エキス寒天やグリセ
ロール・アスパラギン寒天等で中程度に着生し、ホワイ
ト系からグレイ系の色調を呈する。顕微鏡下の観察では
、気菌糸はら旋状を呈し、20個以上の胞子の連鎖が認
められる。胞子の大きさは1.OXo、7μmで円柱状
である。胞子の表面はトゲ状である。@核、胞子のうお
よび遊走子は見出されない。[1 Morphological properties Vegetative hyphae develop well on various agar media, and no division is observed. Aerial hyphae grow moderately on yeast extract/malt extract agar, glycerol/asparagine agar, etc., and are white to gray in color. It has a color tone of When observed under a microscope, aerial hyphae exhibit a spiral shape, and chains of 20 or more spores are observed. The size of the spore is 1. OXo, 7 μm and cylindrical. The surface of the spore is spiny. @Nuclei, sporangia and zoospores are not found.
(Ill 各種培地」ユでの性状
イー・ヒーーシャーリング(E、 B、 Shirli
ng)とデー・ゴツトリーブ(D、 Gott、1ie
b)の方法(インターナショナル・ジャーナル・オブ・
システィマチイック・バクテリオロワー。16巻、31
3頁、1966年)によって調べた本生産菌の培養性状
を法衣に示す。色調は標準色として、カラー・ハーモニ
ー・マニュアル第4版(コンテナー・コーポレーション
・オブ・アメリカ・シカゴ、1958年)を用いて決定
し、色票名とともに括弧内にそのコードを併せて記した
。以下は特記しない限り、27℃、2週間目の各培地に
おける観察の結果である。(Ill. Properties of various media) E. B. Shirli
ng) and Gottlieb (D, Gott, 1ie)
Method b) (International Journal of
Systematic Bacteriolower. Volume 16, 31
The culture characteristics of this producing bacterium, as investigated by the authors (p. 3, 1966), are shown on the robe. The color tone was determined as a standard color using the Color Harmony Manual, 4th edition (Container Corporation of America, Chicago, 1958), and the code was written in parentheses along with the color chart name. The following are the results of observations in each medium at 27°C for 2 weeks unless otherwise specified.
培養性状
(+111生理字的諸性質
(11メラニン色素の生成
(旬チロシン寒天 陰性(ml ペプ
トン・イースト鉄寒天 陰性(ハ)グルコース・ペ
プトン・
ゼラチン培地(21〜23℃) 陰性
(ニ)トリプトン・イースト液 陰性(2)チロ
シナーゼ反応 陽性(3)硫化水素の生
産 陰性(4)硝酸塩の還元
陰性(5)ゼラチンの液化(21〜23℃
)(グルコース・ペプトン・
ゼラチン培地) 陽性
(6)スターチの加水分解 陽性(7)脱
脂乳の凝固(37℃) 陰性(8)脱脂乳のペ
プトン化(37℃)陽性(9)生育温度範囲
17℃〜40’C(10)炭素源の利用法
(ブリーダム・ゴトリーブ寒天培地)
利用する=D−グルコース、し−アラビノース、ラフィ
ノース、メリビ
オース、D−マンニトール、
D−キシロース、L−ラムノ−
ス、i−イノシトール、スフ
ロース
やや利用する:D−フルクトース
CIl+ セルロースの分解 陰性(I
VI 細胞壁組成
細胞壁のジアミノピメリン酸はL L、型である。Culture properties (+111 Physiological properties (11) Production of melanin pigment (shun tyrosine agar negative (ml) peptone yeast iron agar negative (c) glucose peptone gelatin medium (21-23℃) negative (d) tryptone yeast Solution Negative (2) Tyrosinase reaction Positive (3) Production of hydrogen sulfide Negative (4) Reduction of nitrate
Negative (5) Liquefaction of gelatin (21-23℃
) (glucose/peptone/gelatin medium) Positive (6) Hydrolysis of starch Positive (7) Coagulation of skim milk (37°C) Negative (8) Peptonization of skim milk (37°C) Positive (9) Growth temperature range
17°C to 40'C (10) How to use carbon sources (Breedam-Gotlieb agar medium) Used = D-glucose, arabinose, raffinose, melibiose, D-mannitol, D-xylose, L-rhamnose, i-inositol, sufrose slightly utilized: D-fructose CIl+ Decomposition of cellulose Negative (I
VI Cell Wall Composition Cell wall diaminopimelic acid is of the LL, type.
以上、本国の菌学的性状を要約すると次のとおりである
。細胞壁中のジアミノピメリン酸はLL型である。気菌
糸の形態はらせん状で、長い胞子鎖を形成する。胞子の
表面はトゲ状である。培養状の諸性質としては、栄養菌
糸はイエロー系あるいはブラウン系の色調を呈し、気菌
糸はホワイト系あるいはグレイ系の色調を呈する6可溶
性色素はチロシン寒天培地でのみブラウン系の色素を産
生する。The mycological characteristics of Japan are summarized as follows. Diaminopimelic acid in the cell wall is of the LL type. The aerial mycelium has a spiral shape and forms long spore chains. The surface of the spore is spiny. Regarding the properties of the culture, vegetative mycelium exhibits a yellow or brown tone, and aerial mycelium exhibits a white or gray tone.6 Soluble pigments produce brown pigments only on tyrosine agar medium.
これらの結果から、本菌株はストレプトミセス属に属す
る菌種であり、ブリドハムとトレスナーの分類(バーシ
ス・マニュアル・オブ・デターミネーティブ・バクテリ
オワジー。第8版、748〜829頁、1974年)に
よるグレイあるいはレッドシリーズに属する菌種である
と考えられる。なお、本菌株はストレプトミセス・エス
ピー−(Stre tom ces Sp、) WK
−1875として、昭和63年2月8日、工業技術院微
生物工業技術研究所に寄託されでいる(微工研菌寄第9
859号)。From these results, this bacterial strain belongs to the genus Streptomyces, according to Bridham and Tresner's classification (Versis Manual of Determinative Bacteriology, 8th edition, pp. 748-829, 1974). It is thought to be a species belonging to the gray or red series. In addition, this strain is Stretomyces Sp. WK
-1875, deposited with the Institute of Microbial Technology, Agency of Industrial Science and Technology on February 8, 1986
No. 859).
本発明による抗生物質WK−1875生産菌を培養する
ための培地としては、ストレプトミセス属の微生物の培
養に適する炭素源、窒素源、無機物、必要に応じてその
他の宋養物を程よく含有する合成培地または天然培地を
使用することができる。The medium for culturing the antibiotic WK-1875-producing microorganism according to the present invention is a synthetic medium containing appropriate amounts of carbon sources, nitrogen sources, inorganic substances, and, if necessary, other nutrients suitable for culturing Streptomyces microorganisms. Media or natural media can be used.
培地に使用されろ炭素源、窒素源は、使用菌株の利用可
能なものならばいずれの種類でもよい。The carbon source and nitrogen source used in the culture medium may be any type as long as they are available to the strain used.
例えば、炭素源としてはグルコース、グリセロール、フ
ラクトース、マルトース、マンニット、キシロース、ガ
ラクトース、リボース、澱粉またはその加水分解物等の
種々の炭水化物が使用できる。その濃度は通常、培地に
対して0.2%〜5%(グルコース換算)が好ましい、
また、グルコン酸、ピルビン酸、乳酸、酢酸等の各種有
機酸、グリシン、グルタミン酸、アラニン等の各種アミ
ノ酸、さらにはメタノール、エタノール等のアルコール
類やノルマルパラフィン等の各種の非芳香族炭化水素、
あるいは植物性もしくは動物性の各種の油脂等も使用可
能である。For example, various carbohydrates such as glucose, glycerol, fructose, maltose, mannitol, xylose, galactose, ribose, starch or its hydrolyzate can be used as the carbon source. Its concentration is usually preferably 0.2% to 5% (in terms of glucose) based on the medium.
In addition, various organic acids such as gluconic acid, pyruvic acid, lactic acid, and acetic acid, various amino acids such as glycine, glutamic acid, and alanine, alcohols such as methanol and ethanol, and various non-aromatic hydrocarbons such as normal paraffin,
Alternatively, various vegetable or animal fats and oils can also be used.
窒素源としては、アンモニア、塩化アンモニウム、燐酸
アンモニウム、硫酸アンモニウム、Ii1!1Mアンモ
ニウム等の各種の無機酸あるいは有機酸のアンモニウム
塩類、尿素、ペプトン、NZ−アミン、肉エキス、酵母
エキス、乾燥酵母、コーンスチープリカー、カゼイン加
水分解物、フィツシュミールあるいはその消化物、大豆
粉あるいはその消化物、脱脂大豆あるいはその消化物、
輔加水分解物等の含窒素有機物、さらにはグリシン、グ
ルタミン酸、アラニン等の各種アミノ酸が使用可能であ
る。Nitrogen sources include ammonia, ammonium chloride, ammonium phosphate, ammonium sulfate, ammonium salts of various inorganic or organic acids such as Ii1!1M ammonium, urea, peptone, NZ-amine, meat extract, yeast extract, dried yeast, and corn starch. Cheap liquor, casein hydrolyzate, fitschmeal or its digested product, soy flour or its digested product, defatted soybean or its digested product,
Nitrogen-containing organic substances, such as hydrolyzates of soybeans, and various amino acids, such as glycine, glutamic acid, and alanine, can be used.
無機物としては各種燐酸塩、硫酸マグネシウム、食塩等
、さらに微社の重金属塩が使用される。As inorganic substances, various phosphates, magnesium sulfate, common salt, etc., and heavy metal salts of Weisha are used.
栄養要求性を示す変異株を用いる場合には、当然その栄
養要求を満足させる物質を培地に加えなければならない
が、この種の栄養素は、天然物を含む培地を使用する場
合には特に添加を必要としない場合がある。When using a mutant strain that exhibits auxotrophy, it is naturally necessary to add substances that satisfy its nutritional needs to the culture medium, but this kind of nutrients should especially not be added when using a medium containing natural products. It may not be necessary.
発酵は振盪培養または通気撹拌深部培養等の好気条件下
で行なう。k@養湯温度通常20”C〜40℃で、pa
tは4〜9(特に7付近)である。培養期間は通常1〜
7日で菌体内外にWK−1875が生成蓄積する。Fermentation is carried out under aerobic conditions such as shaking culture or submerged culture with aeration and stirring. k@Nursing water temperature usually 20"C to 40C, pa
t is 4 to 9 (especially around 7). The culture period is usually 1~
WK-1875 is produced and accumulated inside and outside the bacterial cells in 7 days.
培養終了後に培養物よりW K −1875を例えば次
の方法で採取する。After completion of the culture, WK-1875 is collected from the culture, for example, by the following method.
培養物を遠心分離により濾液と沈殿物とに分離する。濾
液から多孔性高分子樹脂に吸着させ、溶出さることによ
り抽出する。抽出物を適宜濃縮乾固することによりWK
−1875の粗物質を得る。粗物質はさらに、脂溶性物
質の精製に通常用いられる公知の方法、例えばシリカゲ
ル等の吸着剤、ゲル濾過剤などを用いる各種クロマトグ
ラフィー法、eRm法、塩析法等を単独または適宜組み
合わせることにより精製する。WK−1875の精製に
好適な例として、シリカゲルを用い、溶出溶液としてク
ロロホルムとメタノールの混液を用いる直線濃度勾配溶
出法によるカラムクロマトグラフィー法があげられる。The culture is separated into a filtrate and a precipitate by centrifugation. It is extracted from the filtrate by adsorbing it onto a porous polymer resin and eluting it. By appropriately concentrating the extract to dryness, WK
-1875 crude material is obtained. The crude substance is further purified by known methods commonly used for the purification of fat-soluble substances, such as various chromatography methods using adsorbents such as silica gel, gel filtration agents, etc., eRm method, salting-out method, etc. alone or in appropriate combinations. refine. A suitable example for purifying WK-1875 is a column chromatography method using silica gel and a linear concentration gradient elution method using a mixture of chloroform and methanol as an eluent.
これらの方法で得られる活性画分を′a縮乾固すること
によりWK−1875の精製粉末を得ることができる。A purified powder of WK-1875 can be obtained by condensing the active fraction obtained by these methods to dryness.
本明細書において、WK〜1875の検出および定量は
、シリカゲル薄層クロマトグラフィー(メルク社製、シ
リカゲル、薄層板No、 5554、厚さ0.2mm、
展開溶媒:クロロホルム/メタノール=5 : 1.W
K−1875のRf値060付近)およびフィトフトー
ラ・パラシチカ・バール・ニコチアナエ(Ph to
hthorap var、 n1cotianael
K F −265およびムコール・ラセモサス 障匹虹
racemosus)KF−223を用いる生物学的検
定法によった。In this specification, WK~1875 was detected and quantified using silica gel thin layer chromatography (manufactured by Merck & Co., Ltd., silica gel, thin layer plate No. 5554, thickness 0.2 mm,
Developing solvent: chloroform/methanol = 5:1. W
K-1875 Rf value around 060) and Phytophthora parasitica var. Nicotianae (Ph to
hthorap var, n1cotianael
A biological assay using KF-265 and Mucor racemosus (Mucor racemosus) KF-223 was performed.
以下に実施例を示す。Examples are shown below.
及五勇ユ
ストレプトミセス・エスピー(5ure tom ce
ssp、l WK−1875株(微工研菌寄第985
9号)の斜面培養からl白金耳をl OOmρの種培地
(グリセロール2%、キナ扮2%、Nacf;!。5ure tom ce Ustreptomyces sp.
ssp, l WK-1875 strain (Feikoken Bacterial Serial No. 985
From a slant culture of No. 9), add 1 platinum loop to OOmρ seed medium (2% glycerol, 2% cinchona, Nacf;!.
0.3%、pH7)を入れた500rr+2容の坂ロフ
ラスコに接種し、27℃で2日間振需培養して種培養液
を得た。0.3%, pH 7) was inoculated into a 500rr + 2 volume Sakalo flask, and cultured with shaking at 27°C for 2 days to obtain a seed culture solution.
こうして得られた種培養液400mj2を、種培地と同
一組成(pH7)の培地20βを入れた30Ωのジャー
ファーメンタ−に移植し、27℃で3日間通気撹拌培養
(通気量:1OIl/分、撹拌:25Orpm)を行な
った。発泡を押えるためにアデカノールLG−109(
旭電化社製)を適宜添加した。400mj2 of the seed culture solution obtained in this way was transplanted into a 30Ω jar fermenter containing 20β of a medium with the same composition as the seed medium (pH 7), and cultured with aeration at 27°C for 3 days (aeration rate: 1OIl/min, Stirring: 25 rpm) was performed. Adekanol LG-109 (
(manufactured by Asahi Denka Co., Ltd.) was added as appropriate.
培養液151に等〒の酢酸エチルを加えて活性物質を抽
出し、酢酸エチル層を濃縮乾固して油状物質45gを得
た。油状物質を200mβのクロロホルムに溶解し、不
溶物を除去した。クロロホルムにg4したシリカゲル(
約1kg)を充填したカラム(約22.6cmX75c
m)の上端に、上記の油状物質を少鼠のシリカゲルとと
もに負荷し、クロロホルム/メタノール(5:l。An equal volume of ethyl acetate was added to the culture solution 151 to extract the active substance, and the ethyl acetate layer was concentrated to dryness to obtain 45 g of an oily substance. The oily substance was dissolved in 200 mβ of chloroform and insoluble materials were removed. G4 silica gel in chloroform (
column (approx. 22.6 cm x 75 cm) packed with
m) was loaded with the above oil together with a small amount of silica gel and chloroform/methanol (5:l).
v/v)(342)、クロロホルム/メタノール(3:
1 、V/V)(2氾)で溶出した6分画容徂は約2
0 mβとした。活性画分(No、106〜185)を
集め、減圧下で濃縮することにより、淡褐色の粗粉末3
.5gを得た。この粗粉末(3,0g)を常法により少
咀のシリカゲルに吸着させた。これを、ベンゼンに懸濁
したシリカゲルを充填したカラム(230mfi、1.
1cmX60cm)の上端に負荷し、
ベンゼン/アセトン 50:l(v/v)tt
20 : l (v/v)tt
l O: 1 (v/v)n 5 :
1 (v/v)// 2:l(v/v
)の順に溶出溶媒を順次変えながら、各々約150〜2
00mβずつ溶出した。分画容Tは約IQm℃であった
。活性画分(No、29〜78)のうち、最も活性の高
い両分(No、46〜51)を集め、減圧下で濃縮する
ことにより、WK−1875の白色精製粉本440mg
をえた。本試料はシリカゲル薄層クロマトグラフィーに
おいてクロロホルム/メタノール(5:l、v/v)、
ベンゼン/アセトン(10・1.v/v)で展開した場
合、川−スポットを与えた。また逆相型カラムを用いる
高速液体クロマトグラフィーで単一ピークを与えた。v/v) (342), chloroform/methanol (3:
The volume of the 6 fractions eluted with 1, V/V) (2 floods) was approximately 2
It was set to 0 mβ. The active fractions (No. 106-185) were collected and concentrated under reduced pressure to obtain light brown crude powder 3.
.. 5g was obtained. This coarse powder (3.0 g) was adsorbed onto a small amount of silica gel by a conventional method. This was applied to a column packed with silica gel suspended in benzene (230 mfi, 1.
1 cm x 60 cm), and benzene/acetone 50:l (v/v) tt
20: l (v/v)tt
l O: 1 (v/v) n 5 :
1 (v/v) // 2:l(v/v
) while changing the elution solvent sequentially in the order of approximately 150 to 2
00 mβ was eluted. The fraction volume T was approximately IQm°C. Among the active fractions (No. 29-78), the most active fractions (No. 46-51) were collected and concentrated under reduced pressure to obtain 440 mg of white purified powder of WK-1875.
I got it. This sample was analyzed using silica gel thin layer chromatography using chloroform/methanol (5:l, v/v).
When developed with benzene/acetone (10.1.v/v) gave river-spots. A single peak was also obtained by high-performance liquid chromatography using a reversed-phase column.
本精製粉末の理化学的性質は、WI記のとおりであった
。The physicochemical properties of this purified powder were as described in WI.
2旦1と凱果
抗生物質WK−1875は、主として植物病原性真菌に
活性を示すので、例えば農薬として有用であることが期
待される。The antibiotic WK-1875 is mainly active against plant pathogenic fungi and is therefore expected to be useful as a pesticide, for example.
第1図はWK−1875の赤外線吸収スペクトル(KB
r法ン、第2図はプロトン核磁気共鳴スペクトル(CD
CI、中)、第3図はC−13核磁気共鳴スペクトル(
CDCIs中)を示す。
特許出願人 北里研究所(社団法人)Figure 1 shows the infrared absorption spectrum of WK-1875 (KB
Figure 2 shows the proton nuclear magnetic resonance spectrum (CD
CI, middle), Figure 3 shows the C-13 nuclear magnetic resonance spectrum (
(in CDCIs). Patent applicant Kitasato Institute (incorporated association)
Claims (2)
。 [1]融点:116−119℃ [2]元素分析:実測値(%) C64.7±1.0 H9.1±0.3 [3]分子量:740.97 [4]分子式:C_4_0H_5_5O_1_2[5]
比旋光度:[α]^1^8_D−12.1°(c=0.
5、メタノール) [6]紫外線吸収スペクトル(メタノール中):末端吸
収 [7]赤外線吸収スペクトル(KBr法):第1図の通
り [8]プロトン核磁気共鳴スペクトル(CDCl_3中
):第2図の通り [9]C−13核磁気共鳴スペクトル(CDCl_3中
):第3図の通り [10]溶剤に対する溶解性 可溶:メタノール、エタノール、酢酸 エチル、クロロホルム 不溶:水、n−ヘキサン [11]呈色反応 陽性:H_2SO_4 陰性:エールリッヒ反応、ドラーゲン ドルフ反応 [12]酸性、中性、塩基性の別:弱酸性物質[13]
物質の色:白色(1) Antibiotic WK1875 with the following physicochemical properties
. [1] Melting point: 116-119°C [2] Elemental analysis: Actual value (%) C64.7±1.0 H9.1±0.3 [3] Molecular weight: 740.97 [4] Molecular formula: C_4_0H_5_5O_1_2 [5 ]
Specific optical rotation: [α]^1^8_D-12.1° (c=0.
5, methanol) [6] Ultraviolet absorption spectrum (in methanol): terminal absorption [7] Infrared absorption spectrum (KBr method): as shown in Figure 1 [8] Proton nuclear magnetic resonance spectrum (in CDCl_3): as shown in Figure 2 [9] C-13 nuclear magnetic resonance spectrum (in CDCl_3): As shown in Figure 3 [10] Solubility in solvents Soluble: methanol, ethanol, ethyl acetate, chloroform Insoluble: water, n-hexane [11] Presentation Color reaction positive: H_2SO_4 Negative: Ehrlich reaction, Dragendorff reaction [12] Acidic, neutral, basic: Weakly acidic substances [13]
Material color: white
75を生産する能力を有する菌株を培地に培養し、培養
物中に抗生物質WK−1875を生成蓄積させ、該培養
物から WK−1875を採取することを特徴とする抗生物質W
K−1875の製造法。(2) Belongs to the genus Streptomyces and is an antibiotic WK-18
Antibiotic W, characterized in that a strain having the ability to produce 75 is cultured in a medium, antibiotic WK-1875 is produced and accumulated in the culture, and WK-1875 is collected from the culture.
Method for producing K-1875.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63055558A JP2573018B2 (en) | 1988-03-09 | 1988-03-09 | Antibiotic WK-1875 and method for producing the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63055558A JP2573018B2 (en) | 1988-03-09 | 1988-03-09 | Antibiotic WK-1875 and method for producing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH01228484A true JPH01228484A (en) | 1989-09-12 |
JP2573018B2 JP2573018B2 (en) | 1997-01-16 |
Family
ID=13002030
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP63055558A Expired - Lifetime JP2573018B2 (en) | 1988-03-09 | 1988-03-09 | Antibiotic WK-1875 and method for producing the same |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2573018B2 (en) |
-
1988
- 1988-03-09 JP JP63055558A patent/JP2573018B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP2573018B2 (en) | 1997-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS61268187A (en) | Novel antibiotic substance sk-1071 and production thereof | |
US4764602A (en) | Antibiotics, and their production | |
US4332902A (en) | Antibiotic substance | |
US4940582A (en) | Antibiotic YI-HU3 | |
JPH01228484A (en) | Antibiotic substance wk-1875 and production thereof | |
EP0189330A2 (en) | Antitumor antibiotics and their production | |
JPH06234784A (en) | New antibiotic sf 2768 substance and its production | |
JPH0310692A (en) | Antibiotic substance om-5714 and production thereof | |
JPS6034556B2 (en) | Antibiotic C-15003 | |
JPH02306992A (en) | Antibiotic pk-1061g and pk-1061h and production thereof | |
JPS6348284A (en) | Novel antibiotic yp-02908l-a and production thereof | |
JPH0366307B2 (en) | ||
JPS61146188A (en) | Antibiotic substance rk-419 and preparation thereof | |
JPH02312586A (en) | New physiologically active substance sn-198c-forming bacterium, new physiologically active substance sn-198c and its production | |
JPH0366308B2 (en) | ||
JPH01199582A (en) | Novel antibiotic fo-125a4, a5 or b and production thereof | |
JPS6167492A (en) | Novel antibiotic substance ss21020a and its preparation | |
JPS63280073A (en) | Novel antibiotic yp-02978l-c and production thereof | |
JPS61115081A (en) | Novel antibiotic ss21020d and production thereof | |
JPH0680607A (en) | Malbranicin | |
JPS6119494A (en) | Novel physiologically active substance ss33410 and its preparation | |
JPS61291594A (en) | Novel physiologically active substance ss48727e and production thereof | |
JPS61185191A (en) | Novel antibiotic substance omr-59 and preparation thereof | |
JPH0637519B2 (en) | Novel antibiotic globopeptin and method for producing the same | |
JPS60126093A (en) | Novel antibiotic substance ss7313b and its production |